News

Article

AJMC® in the Press, May 31, 2024

Author(s):

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from McKnights Senior Living referenced a study to be published in the August 2024 issue of The American Journal of Managed Care® (AJMC®). The article, “Care Management Improves Total Cost of Care for Patients With Dementia,” found that a collaborative dementia care program had financial benefits in a managed Medicare population.

An article from BlackDoctor.org referenced a video interview published on AJMC.com, the website of AJMC. The interview, “Dr Chesahna Kindred Addresses Diversity Barriers in Clinical Trials,” highlighted ongoing barriers to clinical trial participation and ways to ensure Black patients are included in clinical trials for psoriasis.

Related Videos
Susan Sabo-Wagner, MSN, RN, OCN.
Screenshot of Scott Soefje, PharmD, BCOP, during a video interview with. the AJMCtv logo in the top corner
Michael Lynch, MD, UPMC
Sophia Humphreys, PharmD, MHA, BCBBS
Ticiana Leal, MD, Emory Winship Cancer Institute
dr ian neeland
Javed Butler, MD
Neil Goldfarb, Greater Philadelphia Business Coalition on Health
dr manisha jhamb
Martin Kolb, MD, PhD, professor of medicine at McMaster University
Related Content
Doctor holding tablet with AI graphics | Image credit: LALAKA – stock.adobe.com
September 7th 2024

Ethical Considerations for AI in Clinical Decision-Making

Hayden E. Klein
Speakers at the European Respiratory Society Congress 2024 highlighted the potential of artificial intelligence (AI) in transforming respiratory health care, while also raising important ethical concerns related to autonomy, equity, transparency, and sustainability.
Combatting the Opioid Epidemic: Insights From the Front Lines
September 2nd 2024

Combatting the Opioid Epidemic: Insights From the Front Lines

Maggie L. Shaw
September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this first episode, we speak with Michael Lynch, MD, associate professor of emergency medicine at the University of Pittsburgh and an attending emergency physician and medical toxicologist at the University of Pittsburgh Medical Center.
The model’s predictions were in line with established cell distributions within each phenotype of rheumatoid arthritis. | Image credit: ArtemisDiana - stock.adobe.com
September 6th 2024

Machine Learning Effectively Characterizes Rheumatoid Arthritis Subtypes

Victoria Johnson
Investigators noted that a formal independent validation cohort needs to be developed to realize the full potential of the human model.
managed care cast logo
August 22nd 2024

Obesity Uncovered: Dr Eden Miller on US Obesity Epidemic, Insurance Shortcomings

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the August 2024 issue of The American Journal of Managed Care® that reviews the US obesity epidemic and discusses inadequate obesity management insurance coverage.
Tailoring Treatment for AA with Dr Kristen Whitney.
September 6th 2024

Tailoring Treatment for Alopecia Areata

Cameron Santoro
Kristen Whitney, DO, FAAD, determines systemic treatment options for severe alopecia areata based on the patient’s medical history, past treatments tried, potential adverse events, in addition to the weighing risk vs benefit of the therapy and the cost for the patient.
COPD drawing | Image Credit: Ivelin Radkov - stock.adobe.com
September 6th 2024

Roflumilast Linked to Higher 5-Year Mortality in Patients With COPD in US, Germany

Brooke McCormick
A small 5-year all-cause mortality risk increase among patients with chronic obstructive pulmonary disease (COPD) using roflumilast was found in Germany and the US.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo